Guardado en:
| Autores principales: | Liu, Tianyu, Jiang, Sihan, Zhang, Fan, Sun, Kunyang, Head-Gordon, Teresa, Zhao, Hongyu |
|---|---|
| Formato: | Preprint |
| Publicado: |
2026
|
| Materias: | |
| Acceso en línea: | https://arxiv.org/abs/2604.02346 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Agentic AI-assisted coding offers a unique opportunity to instill epistemic grounding during software development
por: Palmblad, Magnus, et al.
Publicado: (2026)
por: Palmblad, Magnus, et al.
Publicado: (2026)
Empirical Evidence for the Fragment level Understanding on Drug Molecular Structure of LLMs
por: Hu, Xiuyuan, et al.
Publicado: (2024)
por: Hu, Xiuyuan, et al.
Publicado: (2024)
De novo Drug Design using Reinforcement Learning with Multiple GPT Agents
por: Hu, Xiuyuan, et al.
Publicado: (2023)
por: Hu, Xiuyuan, et al.
Publicado: (2023)
Zero-Shot 3D Drug Design by Sketching and Generating
por: Long, Siyu, et al.
Publicado: (2022)
por: Long, Siyu, et al.
Publicado: (2022)
Artificial Intelligence Approaches for Anti-Addiction Drug Discovery
por: Chen, Dong, et al.
Publicado: (2025)
por: Chen, Dong, et al.
Publicado: (2025)
Conditional Chemical Language Models are Versatile Tools in Drug Discovery
por: Zhu, Lu, et al.
Publicado: (2025)
por: Zhu, Lu, et al.
Publicado: (2025)
Computational Protein Science in the Era of Large Language Models (LLMs)
por: Fan, Wenqi, et al.
Publicado: (2025)
por: Fan, Wenqi, et al.
Publicado: (2025)
Large Language Model Agent for Modular Task Execution in Drug Discovery
por: Ock, Janghoon, et al.
Publicado: (2025)
por: Ock, Janghoon, et al.
Publicado: (2025)
Mining for Potent Inhibitors through Artificial Intelligence and Physics: A Unified Methodology for Ligand Based and Structure Based Drug Design
por: Li, Jie, et al.
Publicado: (2021)
por: Li, Jie, et al.
Publicado: (2021)
Gradient GA: Gradient Genetic Algorithm for Drug Molecular Design
por: Zhuang, Chris, et al.
Publicado: (2025)
por: Zhuang, Chris, et al.
Publicado: (2025)
Pushing the boundaries of Structure-Based Drug Design through Collaboration with Large Language Models
por: Gao, Bowen, et al.
Publicado: (2025)
por: Gao, Bowen, et al.
Publicado: (2025)
DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery
por: Li, Kun, et al.
Publicado: (2025)
por: Li, Kun, et al.
Publicado: (2025)
ProLLaMA: A Protein Large Language Model for Multi-Task Protein Language Processing
por: Lv, Liuzhenghao, et al.
Publicado: (2024)
por: Lv, Liuzhenghao, et al.
Publicado: (2024)
PKAG-DDI: Pairwise Knowledge-Augmented Language Model for Drug-Drug Interaction Event Text Generation
por: Wang, Ziyan, et al.
Publicado: (2025)
por: Wang, Ziyan, et al.
Publicado: (2025)
DrugImproverGPT: A Large Language Model for Drug Optimization with Fine-Tuning via Structured Policy Optimization
por: Liu, Xuefeng, et al.
Publicado: (2025)
por: Liu, Xuefeng, et al.
Publicado: (2025)
Leveraging Partial SMILES Validation Scheme for Enhanced Drug Design in Reinforcement Learning Frameworks
por: Wang, Xinyu, et al.
Publicado: (2025)
por: Wang, Xinyu, et al.
Publicado: (2025)
ProtChatGPT: Towards Understanding Proteins with Large Language Models
por: Wang, Chao, et al.
Publicado: (2024)
por: Wang, Chao, et al.
Publicado: (2024)
Deep Learning of Proteins with Local and Global Regions of Disorder
por: Zhang, Oufan, et al.
Publicado: (2025)
por: Zhang, Oufan, et al.
Publicado: (2025)
WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking
por: Liu, Yunchao, et al.
Publicado: (2024)
por: Liu, Yunchao, et al.
Publicado: (2024)
Graph Neural Networks in Modern AI-aided Drug Discovery
por: Zhang, Odin, et al.
Publicado: (2025)
por: Zhang, Odin, et al.
Publicado: (2025)
Quantum-machine-assisted Drug Discovery
por: Zhou, Yidong, et al.
Publicado: (2024)
por: Zhou, Yidong, et al.
Publicado: (2024)
AI-driven Alternative Medicine: A Novel Approach to Drug Discovery and Repurposing
por: Bilokon, Oleksandr, et al.
Publicado: (2024)
por: Bilokon, Oleksandr, et al.
Publicado: (2024)
Biological Insights from Integrative Modeling of Intrinsically Disordered Protein Systems
por: Liu, Zi Hao, et al.
Publicado: (2024)
por: Liu, Zi Hao, et al.
Publicado: (2024)
A Foundation Chemical Language Model for Comprehensive Fragment-Based Drug Discovery
por: Ho, Alexander, et al.
Publicado: (2025)
por: Ho, Alexander, et al.
Publicado: (2025)
ESM All-Atom: Multi-scale Protein Language Model for Unified Molecular Modeling
por: Zheng, Kangjie, et al.
Publicado: (2024)
por: Zheng, Kangjie, et al.
Publicado: (2024)
How Evaluation Choices Distort the Outcome of Generative Drug Discovery
por: Özçelik, Rıza, et al.
Publicado: (2024)
por: Özçelik, Rıza, et al.
Publicado: (2024)
DrugCLIP: Contrastive Drug-Disease Interaction For Drug Repurposing
por: Lu, Yingzhou, et al.
Publicado: (2024)
por: Lu, Yingzhou, et al.
Publicado: (2024)
Rethinking Drug-Drug Interaction Modeling as Generalizable Relation Learning
por: Xu, Dong, et al.
Publicado: (2026)
por: Xu, Dong, et al.
Publicado: (2026)
DrugLLM: Open Large Language Model for Few-shot Molecule Generation
por: Liu, Xianggen, et al.
Publicado: (2024)
por: Liu, Xianggen, et al.
Publicado: (2024)
Contrastive Multi-Task Learning with Solvent-Aware Augmentation for Drug Discovery
por: Lan, Jing, et al.
Publicado: (2025)
por: Lan, Jing, et al.
Publicado: (2025)
FlexSBDD: Structure-Based Drug Design with Flexible Protein Modeling
por: Zhang, Zaixi, et al.
Publicado: (2024)
por: Zhang, Zaixi, et al.
Publicado: (2024)
Computational Methods to Investigate Intrinsically Disordered Proteins and their Complexes
por: Liu, Zi Hao, et al.
Publicado: (2024)
por: Liu, Zi Hao, et al.
Publicado: (2024)
Physicochemically Informed Dual-Conditioned Generative Model of T-Cell Receptor Variable Regions for Cellular Therapy
por: Ma, Jiahao, et al.
Publicado: (2025)
por: Ma, Jiahao, et al.
Publicado: (2025)
Pre-Training on Large-Scale Generated Docking Conformations with HelixDock to Unlock the Potential of Protein-ligand Structure Prediction Models
por: Liu, Lihang, et al.
Publicado: (2023)
por: Liu, Lihang, et al.
Publicado: (2023)
MeTime: An R package for reproducible longitudinal metabolomics data analysis
por: Marella, Bharadwaj, et al.
Publicado: (2026)
por: Marella, Bharadwaj, et al.
Publicado: (2026)
Structure-Aware Contrastive Learning with Fine-Grained Binding Representations for Drug Discovery
por: Lan, Jing, et al.
Publicado: (2025)
por: Lan, Jing, et al.
Publicado: (2025)
Fragment and Geometry Aware Tokenization of Molecules for Structure-Based Drug Design Using Language Models
por: Fu, Cong, et al.
Publicado: (2024)
por: Fu, Cong, et al.
Publicado: (2024)
Structure-Aware Antibody Design with Affinity-Optimized Inverse Folding
por: Zhao, Xinyan, et al.
Publicado: (2025)
por: Zhao, Xinyan, et al.
Publicado: (2025)
Quantum Long Short-Term Memory for Drug Discovery
por: Zhang, Liang, et al.
Publicado: (2024)
por: Zhang, Liang, et al.
Publicado: (2024)
Systems-Structure-Based Drug Design
por: Zaballa, Vincent D., et al.
Publicado: (2024)
por: Zaballa, Vincent D., et al.
Publicado: (2024)
Ejemplares similares
-
Agentic AI-assisted coding offers a unique opportunity to instill epistemic grounding during software development
por: Palmblad, Magnus, et al.
Publicado: (2026) -
Empirical Evidence for the Fragment level Understanding on Drug Molecular Structure of LLMs
por: Hu, Xiuyuan, et al.
Publicado: (2024) -
De novo Drug Design using Reinforcement Learning with Multiple GPT Agents
por: Hu, Xiuyuan, et al.
Publicado: (2023) -
Zero-Shot 3D Drug Design by Sketching and Generating
por: Long, Siyu, et al.
Publicado: (2022) -
Artificial Intelligence Approaches for Anti-Addiction Drug Discovery
por: Chen, Dong, et al.
Publicado: (2025)